Contemporary Clinical Trials Communications is an international, peer-reviewed, open-access journal that focuses on all aspects of clinical trials. The journal aims to provide a platform for the publication of articles related to the design, conduct, analysis, regulation, and ethics of clinical trials. It seeks to appeal to a broad readership across various disciplines, including medicine, life sciences, pharmaceutical sciences, biostatistics, epidemiology, computer science, management science, behavioral science, and bioethics.
Unlike many disease-specific journals, Contemporary Clinical Trials Communications is not limited to particular medical conditions. It promotes transparency in medical research and aims to reduce publication bias by publishing scientifically valid original research findings, regardless of their perceived importance, significance, or impact. The journal considers both randomized and non-randomized trials within its scope. Common topics covered in the journal include trial design rationale and methods, operational methodologies and challenges, as well as positive and negative trial results.
In addition to original research articles, Contemporary Clinical Trials Communications welcomes other types of communications, such as methodology reviews, perspectives, and discussions. By facilitating the timely dissemination of advances in clinical trials, the journal aims to foster communication and collaboration within the global clinical trials community, ultimately advancing this field of research for the benefit of patients.